News
1d
Medpage Today on MSNTargeted Treatment Improves Disability in Guillain-Barre SyndromeThe primary endpoint, outcome on the GBS Disability Score (GBS-DS) at 8 weeks, showed 29% of patients treated with ...
As it advances a monoclonal antibody targeting Guillain-Barré syndrome (GBS), Annexon Biosciences is embarking on another ...
An unhealthy gut might be fuelling deadly nerve attacks. Here are diet tips to reduce the risk of Guillain-Barré Syndrome naturally.
To beef up its case for tanruprubart, Annexon also announced on Wednesday that a real-world study of the drug likewise showed a “rapid increase in muscle strength” versus current standards of care in ...
Guillain-Barré Syndrome (GBS) is a rare neuromuscular condition that can cause rapid paralysis. Diagnosing GBS is challenging, and misdiagnosis can lead to delayed treatment and potentially long ...
17d
Amazon S3 on MSNWhat is Guillain-Barré syndrome?Scientists have linked Zika firmly to Guillain-Barré syndrome, known for triggering temporary paralysis.
Five-year-olds can be goofy. That was my first thought several years ago when my son stumbled and fell to the ground.
8d
WVNS-TV on MSNBeckley business trying to raise money to help local kid battling Guillain-Barré SyndromeThe Mad Hatter Club held a spaghetti fundraiser to help a local family. Cage McMillion is a kid from Princeton who is suffering from Guillain-Barré Syndrome or GBS.
Annexon, Inc. (NASDAQ:ANNX) on Tuesday presented data for its late-stage targeted therapy, tanruprubart (formerly ANX005), ...
A bout of food poisoning before they arrived in Nelson for a summer holiday led to the 15-year-old developing alarming post-viral symptoms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results